Thymosin Alpha-1 5 mg
Educational recon guide for a 5 mg Thymosin α1 research vial and multi-mg biweekly unit mapping. Research use only — not Zadaxin.
Vial size
Same research phases — calculator defaults and unit math match the selected vial strength.
Vial
5 mg
Your BAC water
1 mL
Concentration
5.00 mg/mL
Per unit
~50.0 mcg
Frequency
Often 2× weekly subcutaneous in clinical monographs (e.g. ~1.6 mg)
Route
Subcutaneous
Live reconstitution calculator
Defaults match this guide (5 mg + 1 mL BAC). Change water or dose and the unit tables below update automatically.
Step 1
Reconstitution
Peptide amount in the vial and how much bacteriostatic water you add.
Step 2
Your dose
Quick-select common research doses (includes 2.5 / 7.5 for dual-agonist ladders) or type any mg / mcg value.
Quick select (mg) — switch units or type any value
Suggested: 50-unit barrel (smallest that fits this draw).
Your draw
Results
Total draw
32 units
Volume
0.320 mL
Doses per vial
3.1
Syringes needed
1
Barrel
50-unit
Fits one syringe?
Yes
50-unit · 0.5 mL
Filled to 32 u
Fill one 50-unit U-100 syringe to about 32 units (0.320 mL).
Weekly research phases
Units and volumes recompute from your Step 1 concentration (1 mL BAC → 5.00 mg/mL · 50.0 mcg/unit).
Standard titration
Zadaxin (thymalfasin) monographs commonly use 1.6 mg SC twice weekly for extended courses. Some secondary sheets discuss ~1.5 mg every few days. Research powders are not the pharmaceutical product.
| Phase | Weekly dose | Units | Volume |
|---|---|---|---|
| Session · 1.6 mg (Zadaxin-style) | 1.60 mg1,600 mcg | 32 u | 0.32 mLCommon clinical monograph amount (often 2× weekly) |
| Session · 1.5 mg | 1.50 mg1,500 mcg | 30 u | 0.30 mLNear-equivalent educational amount |
Advanced / higher-end
Faster escalation discussed in research communities — not a clinical recommendation
| Phase | Weekly dose | Units | Volume |
|---|---|---|---|
| Session · 3 mg | 3 mg3,000 mcg | 60 u | 0.60 mLHigher educational amount seen in some secondary sheets |
Supplies planner
Using the guide’s phase ladder (1.6 mg → 1.5 mg weekly (phase ladder)) over a 8-week schedule. Set a dose in Step 2 to plan supplies at your own amount.
Your recon
1 mL · 5.00 mg/mL
Dose in plan
Phase ladder
Syringe size
100-unit
Horizon
8-week schedule
Thymosin Alpha-1 5 mg vials
3 vials
~12.4 mg mg total peptide over this 8-week schedule at 1.6 mg → 1.5 mg weekly (phase ladder). Each vial holds 5 mg.
Bacteriostatic water
1 × 3 mL bottle
1 mL BAC per vial × 3 vials = 3.0 mL total. Buy as 1× 3 mL bottle or 1× 10 mL bottle (whichever you stock).
U-100 insulin syringes (100-unit)
8+ syringes
About one 100-unit syringe per injection for this schedule. Keep a few spares.
Alcohol swabs & sharps
~22 swabs · 1 sharps container
Wipe vial stopper and injection site each time. Dispose needles in a proper sharps container.
Reconstitution steps
- Allow the lyophilized 5 mg Thymosin α1 vial and bacteriostatic water to reach room temperature.
- Draw 1.0 mL bacteriostatic water (default for this guide).
- Inject BAC slowly down the inner wall of the vial — avoid blasting the powder cake.
- Gently swirl or roll until the solution is clear. Do not shake hard (foaming).
- Label with recon date and concentration (e.g. "5.0 mg/mL").
- Refrigerate at 2–8 °C (35–46 °F), protected from light. Prefer using a reconstituted multi-dose vial within ~28 days with sterile technique.
Storage
Lyophilized
Keep dry powder cold and dark when possible (−20 °C / −4 °F preferred for long-term research stock).
Reconstituted
Refrigerate at 2–8 °C (35–46 °F). Avoid freeze–thaw of the working solution. Prefer finishing within ~28 days.
- ·Write recon date and BAC volume on the label.
- ·Protect from light during storage.
- ·Discard if cloudy, particulates, or odd odor appear after reconstitution.
Protocol notes
- ·Immune-modulating thymic peptide with pharmaceutical history (thymalfasin/Zadaxin) in some regions.
- ·Research powders ≠ Zadaxin.
- ·Research use only.
Research context & considerations
Thymosin alpha-1 has been studied and used for immune modulation (viral hepatitis and other contexts depending on region). Research-market vials are not a substitute for regulated product under clinician care.
- ·Injection-site reactions common.
- ·Immune-active — clinical context matters.
- ·Not FDA-approved as a research-vial consumer product in this channel.
- ·Pregnancy out of scope.
Catalog match
Thymosin alpha 1 (TA5)
5mg x 10 vials · from $45